Thu. 7 Mar 2024, 4:19pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.420) per share which missed the analyst consensus estimate of $(0.330) by 27.27 percent. The company reported quarterly sales of $2.000 million which beat the analyst consensus estimate of $1.977 million by 1.17 percent. This is a 53.85 percent increase over sales of $1.300 million the same period last year.